Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Gene Ther ; 13(14): 1783-90, 2002 Sep 20.
Article in English | MEDLINE | ID: mdl-12396630

ABSTRACT

Guidelines for testing gene therapy products for ecotropic replication-competent retrovirus (Eco-RCR) have not been delineated as they have for amphotropic viruses. To evaluate biologic assays that can detect these viruses, we compared an S(+)/L(-) assay and a marker rescue assay designed specifically for Eco-RCR detection. Moloney murine leukemia virus (Mo-MuLV) obtained from the American Type Culture Collection was used as the positive control. For marker rescue, NIH 3T3 cells were transduced with a retroviral vector expressing the neomycin phosphotransferase gene (3T3/Neo). Inoculation and passage of test material in 3T3/Neo cells for 3 weeks (amplification) and subsequent testing in the S(+)/L(-) assay or the marker rescue assay increased the level of sensitivity for virus detection greater than 10-fold compared with direct inoculation of D56 S(+)/L(-) cells. When serial dilutions of Mo-MuLV stock were evaluated, six of six cultures had detectable virus by the S(+)/L(-) and marker rescue assays at dilutions of 10(-5) and 10(-6). At the 10(-7) dilution, five of six assays had detectable virus in both assays. The ability to detect virus-infected cells was also evaluated in a modification that substituted cells for supernatant. Fifteen 3T3/Neo cultures inoculated with 10(6) 293 cells containing 100 or 10 Mo-MuLV/3T3 cells were all positive by marker rescue. For dilution with 1 virus-infected cell per 10(6) 293 cells, 10 of 15 cultures were positive. At the 0.1-cell dilution only 2 of 15 cultures were positive. If we hope to detect one infected cell in a test article, the probability of detecting virus if the assay is performed in triplicate is 96.3%. In summary, after 3 weeks of amplification the S(+)/L(-) and marker rescue assays can detect virus with similar sensitivities. We prefer the marker rescue assay because of the more reliable growth features of NIH 3T3 cells compared with the D56 cell line. For laboratories analyzing clinical materials, this report may prove useful in establishing detection assays for Eco-RCR.


Subject(s)
Biological Assay , Genetic Therapy/standards , Genetic Vectors/physiology , Kanamycin Kinase/analysis , Retroviridae/isolation & purification , Spleen Focus-Forming Viruses/isolation & purification , Virus Replication , 3T3 Cells/virology , Animals , Cell Line/virology , Defective Viruses/physiology , Genes, Reporter , Genetic Markers , Humans , Kanamycin Kinase/genetics , Kidney , Mice , Moloney murine leukemia virus/physiology , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/genetics , Retroviridae/physiology , Safety , Sarcoma Viruses, Murine/physiology , Sensitivity and Specificity , Spleen Focus-Forming Viruses/physiology , Transduction, Genetic
2.
J Virol ; 72(3): 2272-9, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9499086

ABSTRACT

We previously reported (N. Watanabe, M. Nishi, Y. Ikawa, and H. Amanuma, J. Virol. 65:132-137, 1991) that the mutant Friend spleen focus-forming virus (F-SFFV(MS)), which encodes a mutant gp55 membrane glycoprotein with an ecotropic env gp70 sequence, was nonpathogenic. Here we injected the F-SFFV(MS)-Friend murine leukemia virus (F-MuLV) clone 57 complex into newborn DBA/2 mice. We obtained four groups of pathogenic variant F-SFFV complexes, each showing a different degree of pathogenicity in adult mice and a different gp55 profile. Of these, group 1 variant F-SFFV was particularly interesting, because it was the most frequently obtained and because it produced doublet bands of gp55 (59 and 57 kDa), neither of which reacted with the nonecotropic gp70-specific monoclonal antibody, and because its DNA intermediate did not hybridize with the nonecotropic env-specific probe. Cloning and DNA sequence analysis of the env region of one isolate of the group 1 variant F-SFFV revealed that this virus consisted of two distinct F-SFFV genomes; one (clone 117) differed from the other (clone 118) due to the presence of a 39-bp in-frame deletion. Reconstitution to full-length F-SFFV genomes and a pathogenicity assay showed that each reconstituted F-SFFV was pathogenic, with clone 117 showing a higher degree of pathogenicity than clone 118. Both reconstituted F-SFFVs caused activation of the mouse erythropoietin receptor in the factor-independent cell proliferation assay, although much less efficiently than the wild-type polycythemia-inducing isolate F-SFFVp. Clone 118 produced a gp55 of 59 kDa, while clone 117 produced one of 57 kDa. Clone 118 had a substitution by the F-MuLV clone 57 gp70 sequence, indicating that it was derived from the F-SFFV(MS) env gene by a homologous recombination with the F-MuLV clone 57 env gene. The site of the 39-bp deletion in clone 117 corresponded to the portion of the clone 118 sequence which was unique to the ecotropic env genes. These results indicated the importance for the biological activity of gp55 of the sequences in the gp70 differential region, which are contained in both polytropic and ecotropic env genes.


Subject(s)
Retroviridae Proteins, Oncogenic/genetics , Spleen Focus-Forming Viruses/genetics , Viral Envelope Proteins/genetics , 3T3 Cells , Amino Acid Sequence , Animals , Animals, Newborn , Base Sequence , Cloning, Molecular , DNA, Viral , Gene Products, env/genetics , Leukemia Virus, Murine , Mice , Mice, Inbred DBA , Molecular Sequence Data , Receptors, Erythropoietin/metabolism , Sequence Homology, Nucleic Acid , Spleen Focus-Forming Viruses/isolation & purification , Spleen Focus-Forming Viruses/pathogenicity , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/metabolism
4.
Leukemia ; 6 Suppl 3: 49S-53S, 1992.
Article in English | MEDLINE | ID: mdl-1602827

ABSTRACT

In the murine system natural hybridoma formation was observed first in 1968-9. In the #620 to 818 system a mouse leukemia virus-(MLV-) producer diploid lymphoma cell fused with an immune plasma cell. The tetraploid fusion product cells grew in suspension cultures and as ascites tumors in mice and continued the production of MLV particles and MLV-neutralizing antibodies. Analogy between the #620 to 818 system and the origin of RS cells is proposed. Indirect evidence suggests retroviral infection of the mononuclear HD cell which presumably is an interdigitating reticulum (IR) cell. Reactive B and T cells interact in an abnormal manner and fuse with the retrovirally infected IR cell. The fusion product cells display hyperdiploidy and a disarray of markers as IR markers are lost due to dedifferentiation (and regained upon differentiation induction) and B and/or T cell markers are gained. Conventional theories for the origin of RS cells fail to explain the great heterogeneity of their markers. Derivation of RS cells from IR cells and B and/or T lymphocytes as natural hybridomas offers plausible explanation for all the features of RS cells.


Subject(s)
Antibodies, Viral/analysis , Reed-Sternberg Cells/microbiology , Spleen Focus-Forming Viruses/isolation & purification , Animals , Hodgkin Disease/microbiology , Hodgkin Disease/pathology , Hybridomas/pathology , Mice , Microscopy, Immunoelectron , Neutralization Tests , Reed-Sternberg Cells/immunology , Reed-Sternberg Cells/pathology , Spleen Focus-Forming Viruses/immunology
5.
Int J Hematol ; 54(2): 117-24, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1660735

ABSTRACT

Mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC-P) have been used as a leukemic mouse model. In the present study, purified iron-saturated human lactoferrin (LF) and recombinant murine (rmu) interferon-gamma (IFN-gamma), alone or in combination, were used to influence disease progression in virally infected mice. DBA/2 mice were injected i.v. with FVC-P, and were treated s.c. with 100 micrograms LF at day 7, and/or rmuIFN-gamma at 5 x 10(4) units/day for 3 days beginning at day 6 after viral infection. Mice were assessed for survival, and also 14 days after virus inoculation, the mice were killed and spleen extracts were assessed for spleen focus forming virus (SFFV) titers by spleen focus forming unit (SFFU) assay, SFFV mRNA and genomic DNA expression, and natural killer (NK) cell activity. Treatment with LF or rmuIFN-gamma alone had little or no effect on SFFU numbers or SFFV mRNA or genomic DNA expression. However, dramatically decreased SFFV titers and levels of SFFV mRNA and genomic DNA were observed in mice treated with the combination of LF and rmuIFN-gamma. NK cell activity decreased by FVC-P was returned to normal levels by LF and rmuIFN-gamma. The combined treatment also enhanced the survival rates of FVC-P-infected mice. The results suggest synergistic suppressive effects of LF with rmuIFN-gamma on disease progression in FVC-P-infected mice. This information might be of significance as a potential therapy for patients with leukemia and those infected with retroviruses.


Subject(s)
Antiviral Agents/therapeutic use , Friend murine leukemia virus , Interferon-gamma/therapeutic use , Lactoferrin/therapeutic use , Leukemia, Experimental/drug therapy , Polycythemia/drug therapy , Retroviridae Infections/drug therapy , Animals , Antiviral Agents/pharmacology , Drug Synergism , Female , Interferon-gamma/pharmacology , Killer Cells, Natural/immunology , Lactoferrin/pharmacology , Leukemia, Experimental/immunology , Leukemia, Experimental/microbiology , Mice , Mice, Inbred DBA , Organ Size/drug effects , Polycythemia/immunology , Polycythemia/microbiology , Recombinant Proteins , Retroviridae Infections/immunology , Retroviridae Infections/microbiology , Spleen/pathology , Spleen Focus-Forming Viruses/isolation & purification , Spleen Focus-Forming Viruses/physiology , Virus Replication/drug effects
6.
Virology ; 177(2): 837-9, 1990 Aug.
Article in English | MEDLINE | ID: mdl-1973551

ABSTRACT

Young adult C57BL/6 mice are resistant to the replication of Friend virus. We show here that this resistance is not absolute. In 7-week old C57BL/6 mice injected with NB-tropic Friend virus iv, high titers of SFFV could be recovered from the spleen at 8 days after infection but by 21 days, no virus was detectable. A single dose of anti-Thy 1.2 monoclonal antibody iv before FV infection permitted continued replication of SFFV in these animals. This finding strongly supports the hypothesis that SFFV replication in C57BL/6 mice is restricted by a T cell-mediated immune response.


Subject(s)
Antibodies, Monoclonal/immunology , Antigens, Surface/immunology , Friend murine leukemia virus/physiology , Immunosuppression Therapy , Leukemia Virus, Murine/physiology , Spleen Focus-Forming Viruses/physiology , Virus Replication , Aging , Animals , Immunity, Innate , Mice , Mice, Inbred C57BL , Spleen/microbiology , Spleen Focus-Forming Viruses/immunology , Spleen Focus-Forming Viruses/isolation & purification , Thy-1 Antigens
7.
J Virol ; 63(11): 4958-61, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2552176

ABSTRACT

By using a tagged derivative of Friend spleen focus-forming virus, we previously obtained evidence that proviral integration(s) in the host genome can cause erythroblast immortality by abrogating the commitment of the cell to differentiate (C. Spiro, B. Gliniak, and D. Kabat, J. Virol. 62:4129-4135, 1988). Exploiting the fact that each leukemia was a single clone that contained one tagged provirus, we have now molecularly cloned and characterized one common genomic site for immortalizing proviral integrations.


Subject(s)
Cloning, Molecular , Friend murine leukemia virus/genetics , Leukemia Virus, Murine/genetics , Leukemia, Erythroblastic, Acute/microbiology , Lysogeny , Spleen Focus-Forming Viruses/genetics , Animals , Blotting, Southern , DNA, Viral/genetics , Genes, Viral , Mice , Restriction Mapping , Spleen/microbiology , Spleen Focus-Forming Viruses/isolation & purification
8.
Cancer Res ; 47(15): 4184-8, 1987 Aug 01.
Article in English | MEDLINE | ID: mdl-3038309

ABSTRACT

Purified iron-saturated human lactoferrin (LF) was assessed in vivo for effects on the survival rates of C57BL X DBA/2 f1 (hereafter called BD2F1) (Fv-2sr) mice and titers of spleen focus-forming viruses (SFFV) in BD2F1 and DBA/2 (Fv-2ss) mice inoculated with the polycythemia-inducing strain of the Friend virus complex (FVC-P). LF prolonged the survival rates and decreased the titers of SFFV in mice given FVC-P. Titers of SFFV, assayed 14 days after administration of FVC-P, were measured by the spleen focus-forming unit assay in secondary mouse recipients. Decreases in titers of SFFV were apparent when LF was given in vivo as a single bolus dose of 200 micrograms within 2 h of the Friend virus complex (FVC), or as a total dosage of 200 micrograms given on days 1, 2, 4, 7, 9, and 11 after FVC-P, and to a lesser degree when LF was given as a total dosage of 200 micrograms on days 3, 4, 7, 9, and 11 after FVC-P. No decreases in titers of SFFV were detected when LF was given up to 3 days before or more than 3 days after FVC-P. LF did not appear to be directly inactivating the viruses as it did not inactivate the SFFV or the Friend murine leukemia helper virus in vitro. The results suggest that the protective effect of LF in vivo is probably due to an action on cells responding to the FVC or to an action on cells which influence the cells responding to the FVC or which influence the virus. It has been shown elsewhere that LF decreases the percentage of marrow and spleen hematopoietic progenitor cells that are in DNA synthesis in vivo and this may be the means by which the protective effect of LF is mediated in mice given the FVC.


Subject(s)
Antineoplastic Agents/therapeutic use , Friend murine leukemia virus/drug effects , Lactoferrin/therapeutic use , Lactoglobulins/therapeutic use , Leukemia Virus, Murine/drug effects , Leukemia, Experimental/drug therapy , Spleen Focus-Forming Viruses/drug effects , Animals , Antineoplastic Agents/pharmacology , Friend murine leukemia virus/isolation & purification , Friend murine leukemia virus/physiology , Lactoferrin/pharmacology , Leukemia, Experimental/microbiology , Leukemia, Experimental/pathology , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Polycythemia/drug therapy , Polycythemia/microbiology , Polycythemia/pathology , Spleen/microbiology , Spleen/pathology , Spleen Focus-Forming Viruses/isolation & purification , Spleen Focus-Forming Viruses/physiology , Virus Replication/drug effects
9.
J Virol ; 57(1): 349-52, 1986 Jan.
Article in English | MEDLINE | ID: mdl-3001356

ABSTRACT

The Friend spleen focus-forming virus (SFFV) is an envelope gene recombinant between the ecotropic Friend murine leukemia virus and the endogenous xenotropic mink cell focus-forming retroviral sequences. We synthesized an octadecanucleotide complementary to the 3' end of the SFFV env gene designed for discriminating the SFFV proviruses from the xenotropic mink cell focus-forming virus and ecotropic exogenous or endogenous viral sequences. Under appropriate hybridization conditions this probe allowed the identification, in addition to few endogenous DNA fragments, of multiple SFFV proviruses integrated in the genome of Friend malignant cells. Therefore this probe should be of interest in further characterizing the SFFV integration sites and possibly the SFFV ancestor gene.


Subject(s)
DNA, Viral/analysis , Leukemia Virus, Murine/isolation & purification , Leukemia, Experimental/microbiology , Spleen Focus-Forming Viruses/isolation & purification , Animals , Base Sequence , DNA, Neoplasm/analysis , Friend murine leukemia virus/genetics , Genetic Markers , Leukemia, Experimental/genetics , Mice/genetics , Mice/microbiology , Mink Cell Focus-Inducing Viruses/genetics , Nucleic Acid Hybridization , Recombination, Genetic , Spleen Focus-Forming Viruses/genetics , Viral Envelope Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...